Biopharmaceutical Research Company
Policy issues related to access to innovative therapies, particularly focused on sickle cell disease Federal funding for programs authorized under 2018 Sickle Cell Disease (SCD) Research, Surveillance, Prevention, and Treatment Act (P.L. 115-327).
HCR - Health Issues BUD - Budget/Appropriations
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
KING & SPALDING LLP
1700 Pennsylvania Avenue NW, Suite 900, Washington, DC, 20006, US
KENDRICK B MEEK (U.S. Representative (FL-17), 2002-2010) ALLISON F KASSIR AMIRAH SALAAM (Staff, Congressional Black Caucus - Rep. Meek (FL-17), Rep. Carson (IN-7), Rep. Payne, Sr. (NJ-10)) KENDRICK B MEEK (U.S. Representative (FL-17), 2002-2010) AMIRAH SALAAM (Staff, Congressional Black Caucus - Rep. Meek (FL-17), Rep. Carson (IN-07),Rep. Payne, Sr. (NJ-10)) ALLISON F KASSIR VIRAJ M MIRANI (Sen. Coats (IN): COS, Leg. Dir., Dep. COS; Joint Economic Committee: Exec. Dir.; Senate HELP Committee: Policy Adv.; Office of the Director of National Intelligence: Exec. Off.)
U.S. Representative (FL-17), 2002-2010 Staff, Congressional Black Caucus - Rep. Meek (FL-17), Rep. Carson (IN-7), Rep. Payne, Sr. (NJ-10) U.S. Representative (FL-17), 2002-2010 Staff, Congressional Black Caucus - Rep. Meek (FL-17), Rep. Carson (IN-07),Rep. Payne, Sr. (NJ-10) Sen. Coats (IN): COS, Leg. Dir., Dep. COS; Joint Economic Committee: Exec. Dir.; Senate HELP Committee: Policy Adv.; Office of the Director of National Intelligence: Exec. Off.